NCT02517372View on ClinicalTrials.gov

Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

CRD007

All Listed Sponsors
lead

RSPR Pharma AB

INDUSTRY

NCT02517372 - Study in Healthy Volunteers to Document Safety and Tolerability of Increasing Doses Pemirolast | Biotech Hunter | Biotech Hunter